M

Mass General Brigham | MGB MGH Nagrebetsky

Research site

(Unclaimed)

Location

55 Fruit Street, Boston, Massachusetts, United States of America

Site insights

Top conditions

Top treatments

mRNA-2808

SPG302

Parent organization

This site is a part of Mass General Brigham

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 21 total trials

A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

The purpose of this study is to evaluate the safety and tolerability of mRNA-2808 in participants with relapsed or refractory multiple myeloma (RRMM).

Begins enrollment in 1 month

Relapsed or Refractory Multiple Myeloma

Drug: mRNA-2808

Computerized Decision Support to Prevent Stroke in Atrial Fibrillation (AF-ALERT3)

Atrial fibrillation (AF) is the most preventable cause of stroke. However, despite widely available risk stratification tools, numerous options for o...

Begins enrollment in a year or more

Atrial Fibrillation

Stroke

Behavioral: Alert-based computerized decision support